Related Experiment Video
Updated: May 6, 2026
09:04
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
9.4K
Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue
1Laboratory of Clinical Immunology, Department of Microbiology and Immunology, Catholic University of Leuven, Leuven, Belgium.
Allergy
|October 17, 2013
Summary
Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) and VEGF-B expression correlate with nasal polyp (NP) edema and clinical markers. These findings suggest VEGFR1 and VEGF-B are potential therapeutic targets for NP disease.
Area of Science:
- Rhinology and Otolaryngology
- Molecular Biology
- Immunology
Background:
- Nasal polyp (NP) disease is characterized by edema.
- The role of vascular endothelial growth factor (VEGF) family members, including VEGF-A, VEGF-B, placental growth factor (PlGF), and their receptors VEGFR1 and VEGFR2, in NP edema is not fully understood.
Purpose of the Study:
- To investigate the expression of VEGF family members and their receptors in nasal polyps.
- To correlate their expression with clinical, radiological, and edema markers in NP disease.
Main Methods:
- Quantified mRNA and protein levels of VEGF-A, VEGF-B, PlGF, VEGFR1, and VEGFR2 in NP and control tissues.
- Assessed edema using albumin levels and wet/dry ratios.
- Scored CT scans with the Lund-Mackay system and measured IL-5 mRNA expression.
Main Results:
- Significantly higher mRNA expression of VEGFR1 and VEGF-B in NP tissues compared to controls.
- VEGF-B and VEGFR1 expression correlated with NP albumin content, CT scan scores, and IL-5 mRNA levels.
- In vitro stimulation with IL-1β or TNFα reduced VEGFR2 expression in control tissue but not in NP tissue.
Conclusions:
- VEGFR1 and VEGF-B expression levels are associated with edema and clinical indicators of NP disease.
- VEGFR1 and VEGF-B represent promising therapeutic targets for managing nasal polyp edema.
